From: Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer
Clinicopathologic features | n | MUC20 expression n (%) | χ2 | P | |
---|---|---|---|---|---|
Positive | Negative | ||||
Gender | Â | Â | Â | 0.787 | 0.375 |
 Male | 88 | 56(63.6%) | 32(26.4%) |  |  |
 Female | 62 | 35(56.5%) | 27(43.5%) |  |  |
Age(years) | Â | Â | Â | 4.261 | 0.039 |
 <60 | 94 | 63(67.0%) | 31(33.0%) |  |  |
 > = 60 | 56 | 28(50.0%) | 28(50.0%) |  |  |
Tumor size (diameter) | Â | Â | 1.189 | 0.276 | |
 <5 | 87 | 56(64.4%) | 31(35.6%) |  |  |
 > = 5 | 63 | 35(55.6%) | 28(44.4%) |  |  |
Location | Â | Â | Â | 0.224 | 0.636 |
 Colon | 100 | 62(62.0%) | 38(38.0%) |  |  |
 Rectum | 50 | 29(58.0%) | 21(42.0%) |  |  |
Gross appearance | Â | Â | Â | 0.685 | 0.710 |
 Exophytic | 60 | 34(56.7%) | 26(43.3%) |  |  |
 Ulcerative | 87 | 55(63.2%) | 32(36.8%) |  |  |
 Diffusely infiltrative | 3 | 2(66.7%) | 1(33.3%) |  |  |
Differentiation | Â | Â | Â | 0.086 | 0.958 |
 High | 7 | 4(57.1%) | 3(42.9%) |  |  |
 Moderate | 111 | 67(60.4%) | 44(39.6%) |  |  |
 Low | 32 | 20(62.5%) | 12(37.5%) |  |  |
TNM stage | Â | Â | Â | 0.264 | 0.607 |
 II | 80 | 47(58.8%) | 33(41.2%) |  |  |
 III | 70 | 44(62.9%) | 26(37.1%) |  |  |
Recurrence | Â | Â | Â | 5.849 | 0.016 |
 Yes | 47 | 36(76.6%) | 11(33.4%) |  |  |
 No | 90 | 50(55.6%) | 40(44.4%) |  |  |
Status | Â | Â | Â | 5.960 | 0.015 |
 Survival | 93 | 52(55.9%) | 41(44.1%) |  |  |
 Death | 41 | 32(78.0%) | 9(22.0%) |  |  |